GILD vs XENE · P/E 18, rev $7.80B vs $2.55B cap
Gilead Sciences Inc (GILD) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. XENE currently screens at market cap $2.55B.
Not investment advice. Open the GILD and XENE stock pages for the full models.
Not investment advice.